003520.KS

Yungjin Pharm. Co., Ltd. [003520.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

003520.KS Stock Summary

Top 10 Correlated Stocks

003520.KS


In the News

003520.KS Financial details

Company Rating
Neutral
Market Cap
401.45B
Income
-3.88B
Revenue
234.9B
Book val./share
490.08
Cash/share
55.81
Dividend
-
Dividend %
-
Employees
574
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-19.31
Forward P/E
-
PEG
2.35
P/S
1.75
P/B
4.36
P/C
38.52
P/FCF
-23.01
Quick Ratio
-
Current Ratio
1.67
Debt / Equity
0.74
LT Debt / Equity
0.45
-
-
EPS (TTM)
-21.35
EPS next Y
-
EPS next Q
-
EPS this Y
-82.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.27%
Revenue Q/Q
8.32%
EPS Q/Q
32.99%
-
-
-
-
SMA20
3.77%
SMA50
-1.03%
SMA100
0.86%
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-22%
ROC
-0.02%
Gross Margin
30%
Oper. Margin
-1%
Profit Margin
-9%
Payout
-
Shs Outstand
182.89M
Shs Float
86.95M
-
-
-
-
Target Price
-
52W Range
1960.0-3775.0
52W High
-43.05%
52W Low
+9.69%
RSI
58
Rel Volume
1.65
Avg Volume
334.52K
Volume
550.41K
Perf Week
6.44%
Perf Month
6.17%
Perf Quarter
-6.52%
Perf Half Y
-6.52%
-
-
-
-
Beta
0.895
-
-
Volatility
31.9%, 52.72%
Prev Close
1.42%
Price
2150
Change
-1.38%

003520.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.23K1.14K1.07K1.19K1.28K
Net income per share
28-0.73-63.33-120.08-21.19
Operating cash flow per share
51.6779.2745.75-63.48-68.34
Free cash flow per share
-5.9944.8-16.14-135.65-124.32
Cash per share
-4.03-9.9-9.71-3.8555.81
Book value per share
644.35625.68573.48491.38490.08
Tangible book value per share
632.03617.12565.6476.73477.42
Share holders equity per share
644.35625.68573.48491.38490.08
Interest debt per share
83.8141.2172.55219.02379.17
Market cap
1191.01B1470.46B967.5B635.55B397.79B
Enterprise value
1204.99B1477.31B980.1B674.19B457.47B
P/E ratio
236.79-11.05K-83.53-28.94-102.64
Price to sales ratio
5.47.054.932.911.69
POCF ratio
128.31101.43115.62-54.74-31.82
PFCF ratio
-1.11K179.48-327.74-25.62-17.5
P/B Ratio
10.2912.859.227.074.44
PTB ratio
10.2912.859.227.074.44
EV to sales
5.467.0953.091.95
Enterprise value over EBITDA
67.61174.32-152.9-49.3138.73
EV to operating cash flow
129.81101.9117.13-58.07-36.6
EV to free cash flow
-1.12K180.32-332.01-27.17-20.12
Earnings yield
00-0.01-0.03-0.01
Free cash flow yield
00.010-0.04-0.06
Debt to equity
0.130.060.120.440.74
Debt to assets
0.070.040.070.190.29
Net debt to EBITDA
0.780.81-1.96-2.835.05
Current ratio
2.83.271.862.061.69
Interest coverage
23.362.74-66.41-101.06
Income quality
1.85-108.91-0.720.533.23
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.020.020.020.010.01
Research and developement to revenue
0.060.070.070.070.05
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
-1.12-0.43-1.351.140.82
Capex to revenue
-0.05-0.03-0.06-0.06-0.04
Capex to depreciation
-1.35-0.81-1.53-1.7-1.18
Stock based compensation to revenue
00000
Graham number
637.13101.23903.971.15K483.39
ROIC
0.040-0.09-0.050.02
Return on tangible assets
0.030-0.06-0.11-0.02
Graham Net
-91.29-82.35-186.66-272.83-301.52
Working capital
71.54B68.53B41.36B52.56B51.51B
Tangible asset value
113.54B112.87B103.44B87.19B87.32B
Net current asset value
26.64B25.01B478.24M-11.02B-10.4B
Invested capital
0.130.060.120.440.74
Average receivables
57.37B50.49B47.81B51.2B53.61B
Average payables
16.47B11.86B12.83B18.14B20.05B
Average inventory
51.9B53.7B45.54B44.06B55.22B
Days sales outstanding
90.5881.0191.8988.6784.16
Days payables outstanding
35.3827.2641.1749.1743.2
Days of inventory on hand
145.12139.07104.78115.13137.99
Receivables turnover
4.034.513.974.124.34
Payables turnover
10.3213.398.877.428.45
Inventory turnover
2.522.623.483.172.65
ROE
0.040-0.11-0.24-0.04
Capex per share
-57.66-34.47-61.89-72.17-55.98

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
336.73351.61311.84324.61351.64
Net income per share
-96.07-1-9.19-4.79-6.37
Operating cash flow per share
-44.25-22.1617.81-38.99-18.92
Free cash flow per share
-55.98-34.995.59-46.42-44.43
Cash per share
-3.98-16.19-7.11-3.1855.81
Book value per share
508.03582.7482.12477.51490.08
Tangible book value per share
492.89565.7468.53464.67477.42
Share holders equity per share
508.03582.7482.12477.51490.08
Interest debt per share
224.04299255.83311.87368.81
Market cap
614.72B452.32B450.83B420.65B397.79B
Enterprise value
653.36B497.51B495.6B475.58B457.47B
P/E ratio
-9.04-733.75-67.08-120.11-85.32
Price to sales ratio
10.328.357.97.096.19
POCF ratio
-78.53-132.47138.43-58.99-114.93
PFCF ratio
-62.07-83.87440.96-49.55-48.95
P/B Ratio
6.845.045.114.824.44
PTB ratio
6.845.045.114.824.44
EV to sales
10.979.188.698.017.11
Enterprise value over EBITDA
-44.63196.7728.7626.2796.52
EV to operating cash flow
-83.46-145.71152.18-66.69-132.17
EV to free cash flow
-65.97-92.25484.75-56.02-56.29
Earnings yield
-0.030000
Free cash flow yield
-0.02-0.010-0.02-0.02
Debt to equity
0.440.510.520.650.74
Debt to assets
0.190.220.220.260.29
Net debt to EBITDA
-2.6417.872.63.0312.59
Current ratio
2.062.651.831.671.69
Interest coverage
-8.760.52-0.560.532.45
Income quality
0.4622.16-1.948.142.97
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.010.310.30.01
Research and developement to revenue
0.080.050.050.060.02
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
0.270.58-0.690.191.35
Capex to revenue
-0.03-0.04-0.04-0.02-0.07
Capex to depreciation
-0.98-0.9-1.02-0.63-2.18
Stock based compensation to revenue
00000
Graham number
1.05K114.5315.69226.79265.09
ROIC
-0.020000.02
Return on tangible assets
-0.080-0.010-0.01
Graham Net
-282.07-360.29-316.87-330.38-301.52
Working capital
52.56B65.78B49.66B47.96B51.51B
Tangible asset value
87.19B87.18B85.69B84.98B87.32B
Net current asset value
-11.02B-12.03B-12.8B-13.31B-10.4B
Invested capital
0.440.510.520.650.74
Average receivables
51.38B52.16B50.2B52.33B54.86B
Average payables
20.18B21.28B23.66B25.68B22.67B
Average inventory
49.89B50.33B54.92B59.97B62.14B
Days sales outstanding
80.1585.1777.584.2175.79
Days payables outstanding
43.8952.4257.5456.5539.3
Days of inventory on hand
102.75125.11130.36135.86125.53
Receivables turnover
1.121.061.161.071.19
Payables turnover
2.051.721.561.592.29
Inventory turnover
0.880.720.690.660.72
ROE
-0.190-0.02-0.01-0.01
Capex per share
-11.73-12.84-12.22-7.43-25.51

003520.KS Frequently Asked Questions

What is Yungjin Pharm. Co., Ltd. stock symbol ?

Yungjin Pharm. Co., Ltd. is a KR stock and trading under the symbol 003520.KS

What is Yungjin Pharm. Co., Ltd. stock quote today ?

Yungjin Pharm. Co., Ltd. stock price is $2150 today.

Is Yungjin Pharm. Co., Ltd. stock public?

Yes, Yungjin Pharm. Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap